GG
GTHX

Golden Green’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Golden Green’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,000
Closed -$36K – 198
2020
Q4 		$36K Buy
+2,000
New +$29.9K 0.03% 126

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Golden Green's GTHX Position: Q3 2022 in Review

Golden Green sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2022, closing a stake of 11,220 shares — an estimated $55K sold.

Golden Green first reported a position in GTHX in Q4 2020 and held it in 7 quarters. The position peaked at $1.4M in Q1 2021. 104 funds tracked by Wall St. Rank hold GTHX as of Q3 2022.

  • Golden Green reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Golden Green sold 11,220 G1 Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $55K.
  • Golden Green first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Golden Green's G1 Therapeutics, Inc. Common Stock position peaked at $1.4M in Q1 2021.
  • 104 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Golden Green's 13F filing for Q3 2022, filed 14 Oct 2022.